这里是《21健讯Daily》,欢迎与21世纪经济报道新健康团队共同关注医药健康行业最新事件!政策动向国家药监局发布仿制药参比制剂目录(第八十六批)12月20日,国家药监局网站发布仿制药参比制剂目录(第八十六批)。其中,新增33个品规,以及已发布化学仿制药参比制剂增补目录18个。国家医保局发布对个别药企虚开发票制造“两套价格”问题进行关注的函12月20日,国家医疗保障局办公室发布关于对个别药企虚...
Source Link这里是《21健讯Daily》,欢迎与21世纪经济报道新健康团队共同关注医药健康行业最新事件!政策动向国家药监局发布仿制药参比制剂目录(第八十六批)12月20日,国家药监局网站发布仿制药参比制剂目录(第八十六批)。其中,新增33个品规,以及已发布化学仿制药参比制剂增补目录18个。国家医保局发布对个别药企虚开发票制造“两套价格”问题进行关注的函12月20日,国家医疗保障局办公室发布关于对个别药企虚...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.